Power Law company profile

Flexion Therapeutics

Biotech & Life Sciences · Woburn, United States · Founded 2007 · IPO 2014 Thoroughbred

Biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis

Valuation

$428M

Market cap · 2026

Revenue

$174M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

5 investors on Flexion Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Sofinnova Partners

5AM Ventures

Versant Ventures

Series B+ 2 investors entered at this stage

Novo Ventures

Pfizer

Global footprint

Where Flexion Therapeutics has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States92.9%

🇮🇳 India7.1%

2 countries shown

Market sentiment

What the market is saying about Flexion Therapeutics

An AI-synthesized read of the highest-engagement posts about Flexion Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Flexion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles